Stemchymal® is the standardized allogeneic stem cells product isolated from human adipose tissue and produced using Steminent’s proprietary technology platform in accordance to Good Manufacturing Practice (GMP) conditions.

Stemchymal® Technology Platform

The technology behind Steminent’s proprietary cell processing system has been under development for over a decade involving a number of leading stem cell research institutes. Through a series of research projects, from the technology of stem cell isolation from different tissue sources to characterizing stem cell properties, and their related therapeutic potential in various preclinical disease models, Steminent started translating and developing their cell processing platform into a standardized production system in 2009.